Safety and Dosing Evaluation of REG1 Anticoagulation System

NCT00113997 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

106

Enrollment

NIH

Sponsor class

Conditions

Healthy

Interventions

DRUG: REG1

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)